Sale of 2,300 shares at $107.902 per share.
Reporting Person Torley Helen · Officer Title PRESIDENT AND CEO · Transaction Code S
Traded Oct 6, 2026 · Disclosed Oct 8, 2026
Source: SEC Form 4 · 0001159036-26-000140 · filed 2026-10-08 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "HALOZYME THERAPEUTICS, INC. (HALO)." Disclosed 2026-10-08. https://desqlong.com/cards/0001159036-26-000140-2 (retrieved 2026-10-09).